Ampio Pharmaceuticals, Inc.
AMPE
$0.01
-$0.14-96.39%
OTC PK
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 973.00K | 1.07M | 1.22M | 3.82M | 1.96M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.22M | 1.40M | 1.56M | 4.34M | 2.70M |
| Operating Income | -2.22M | -1.40M | -1.56M | -4.34M | -2.70M |
| Income Before Tax | -2.05M | -1.23M | -1.37M | -3.98M | -2.22M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.05M | -1.23M | -1.37M | -3.98M | -2.22M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.05M | -1.23M | -1.37M | -3.98M | -2.22M |
| EBIT | -2.22M | -1.40M | -1.56M | -4.34M | -2.70M |
| EBITDA | -2.22M | -1.40M | -1.56M | -4.22M | -2.52M |
| EPS Basic | -2.48 | -1.53 | -1.82 | -5.27 | -2.95 |
| Normalized Basic EPS | -1.55 | -0.96 | -1.14 | -3.49 | -1.84 |
| EPS Diluted | -2.49 | -1.53 | -1.82 | -5.27 | -3.45 |
| Normalized Diluted EPS | -1.55 | -0.96 | -1.14 | -3.49 | -1.84 |
| Average Basic Shares Outstanding | 828.00K | 804.20K | 754.70K | 754.70K | 753.60K |
| Average Diluted Shares Outstanding | 828.00K | 804.20K | 754.70K | 754.70K | 753.60K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |